ERBB2 and triple-negative breast carcinoma: Among the breast cancer subtypes, human epidermal growth factor receptor 2 (HER2) positive and triple negative (triple-negative breast cancer (TNBC)) are characteristically aggressive, prone to metastasize, and patients show increased recurrence and lower rates of survival than with other subtypes2.